Global markets have recently experienced mixed results, with large-cap technology stocks driving gains in major U.S. indexes, while smaller-cap indexes faced declines. Amid this backdrop, investors may find opportunities in penny stocks—an investment area that remains relevant despite its outdated term. These smaller or less-established companies can offer surprising value and potential upside for those willing to explore beyond the more prominent market players.
Top 10 Penny Stocks Globally
| Name | Share Price | Market Cap | Rewards & Risks |
| Lever Style (SEHK:1346) | HK$1.52 | HK$964.89M | ✅ 4 ⚠️ 1 View Analysis > |
| LexinFintech Holdings (NasdaqGS:LX) | $4.27 | $736.99M | ✅ 4 ⚠️ 2 View Analysis > |
| IVE Group (ASX:IGL) | A$2.92 | A$458M | ✅ 4 ⚠️ 3 View Analysis > |
| TK Group (Holdings) (SEHK:2283) | HK$2.50 | HK$2.09B | ✅ 4 ⚠️ 1 View Analysis > |
| Angler Gaming (NGM:ANGL) | SEK3.60 | SEK269.95M | ✅ 4 ⚠️ 2 View Analysis > |
| CNMC Goldmine Holdings (Catalist:5TP) | SGD1.08 | SGD437.71M | ✅ 4 ⚠️ 2 View Analysis > |
| Deleum Berhad (KLSE:DELEUM) | MYR1.20 | MYR481.86M | ✅ 4 ⚠️ 1 View Analysis > |
| Yangzijiang Shipbuilding (Holdings) (SGX:BS6) | SGD3.46 | SGD13.62B | ✅ 5 ⚠️ 1 View Analysis > |
| Integrated Diagnostics Holdings (LSE:IDHC) | $0.565 | $328.45M | ✅ 4 ⚠️ 2 View Analysis > |
| DXN Holdings Bhd (KLSE:DXN) | MYR0.525 | MYR2.61B | ✅ 5 ⚠️ 0 View Analysis > |
Click here to see the full list of 3,589 stocks from our Global Penny Stocks screener.
Let's review some notable picks from our screened stocks.
Liuzhou Chemical Industry (SHSE:600423)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Liuzhou Chemical Industry Co., Ltd. is a Chinese company that produces and sells hydrogen peroxide, with a market cap of CN¥3.10 billion.
Operations: The company generates revenue of CN¥148.27 million from its chemical industry segment.
Market Cap: CN¥3.1B
Liuzhou Chemical Industry has faced challenges with declining sales and net income, reporting CN¥106.66 million in sales for the first nine months of 2025, down from CN¥123.28 million the previous year. Despite these setbacks, the company maintains a strong balance sheet with short-term assets of CN¥512.5 million exceeding both short and long-term liabilities, and it remains debt-free. However, profitability has been impacted by a large one-off loss of CN¥5.8 million over the past year, contributing to a significant drop in net profit margins from 54.1% to 4.1%. The management team is experienced with an average tenure of nearly eight years.
- Navigate through the intricacies of Liuzhou Chemical Industry with our comprehensive balance sheet health report here.
- Understand Liuzhou Chemical Industry's track record by examining our performance history report.
Shaanxi Beiyuan Chemical Industry Group (SHSE:601568)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Shaanxi Beiyuan Chemical Industry Group Co., Ltd. operates in the chemical industry and has a market capitalization of approximately CN¥15.93 billion.
Operations: No specific revenue segments are reported for Shaanxi Beiyuan Chemical Industry Group Co., Ltd.
Market Cap: CN¥15.93B
Shaanxi Beiyuan Chemical Industry Group Co., Ltd. has experienced a challenging period with declining earnings over the past five years, though recent performance shows improvement with a 12.4% earnings growth in the past year, surpassing industry averages. Despite this, sales have decreased from CN¥7.51 billion to CN¥6.76 billion for the first nine months of 2025 compared to the previous year, and net income slightly fell from CN¥239.84 million to CN¥213.75 million during the same period. The company remains debt-free with short-term assets significantly exceeding liabilities, yet its dividend yield of 2.43% is not well supported by current earnings or cash flows.
- Dive into the specifics of Shaanxi Beiyuan Chemical Industry Group here with our thorough balance sheet health report.
- Evaluate Shaanxi Beiyuan Chemical Industry Group's historical performance by accessing our past performance report.
China Fangda Group (SZSE:000055)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: China Fangda Group Co., Ltd. focuses on the production and sales of curtain wall materials in China, with a market cap of CN¥3.56 billion.
Operations: The company has not reported any specific revenue segments.
Market Cap: CN¥3.56B
China Fangda Group has faced a decline in earnings, with net income dropping to CN¥15.89 million for the first nine months of 2025 from CN¥149.71 million a year ago, alongside reduced sales of CN¥2.56 billion from CN¥3.21 billion. The company's short-term assets of CN¥5.7 billion comfortably cover both its short and long-term liabilities, but its return on equity remains low at 0.2%. Despite an experienced management team and stable weekly volatility, interest coverage is weak at 2x EBIT, and profit margins have contracted significantly to 0.3% from last year's 3.6%.
- Unlock comprehensive insights into our analysis of China Fangda Group stock in this financial health report.
- Explore historical data to track China Fangda Group's performance over time in our past results report.
Next Steps
- Unlock more gems! Our Global Penny Stocks screener has unearthed 3,586 more companies for you to explore.Click here to unveil our expertly curated list of 3,589 Global Penny Stocks.
- Searching for a Fresh Perspective? AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Shaanxi Beiyuan Chemical Industry Group might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com